- Report
- June 2024
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Report
- May 2024
- 298 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Report
- April 2024
- 143 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €882EUR$1,000USD£769GBP
€1102EUR$1,250USD£961GBP
- Report
- March 2024
- 174 Pages
Global
From €5290EUR$6,000USD£4,613GBP
€6612EUR$7,500USD£5,766GBP
- Report
- February 2024
- 200 Pages
Global
From €5290EUR$6,000USD£4,613GBP
€6612EUR$7,500USD£5,766GBP
- Report
- November 2023
- 30 Pages
Global
From €2292EUR$2,600USD£1,999GBP
€2865EUR$3,250USD£2,499GBP
- Report
- May 2023
- 200 Pages
Global
From €5290EUR$6,000USD£4,613GBP
€6612EUR$7,500USD£5,766GBP
- Report
- May 2023
- 220 Pages
Global
From €1763EUR$2,000USD£1,538GBP
€2204EUR$2,500USD£1,922GBP
- Report
- May 2023
- 450 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Report
- April 2023
- 200 Pages
Global
From €2786EUR$3,160USD£2,430GBP
€3483EUR$3,950USD£3,037GBP
- Report
- April 2023
- 500 Pages
Global
From €2292EUR$2,600USD£1,999GBP
€2865EUR$3,250USD£2,499GBP
- Report
- April 2023
- 350 Pages
Global
From €2292EUR$2,600USD£1,999GBP
€2865EUR$3,250USD£2,499GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2292EUR$2,600USD£1,999GBP
€2865EUR$3,250USD£2,499GBP
- Report
- October 2022
- 100 Pages
Global
From €1763EUR$2,000USD£1,538GBP
€2204EUR$2,500USD£1,922GBP
- Report
- September 2022
- 288 Pages
Global
From €6701EUR$7,600USD£5,843GBP
€8376EUR$9,500USD£7,304GBP
- Report
- September 2022
- 239 Pages
Global
From €5290EUR$6,000USD£4,613GBP
€6612EUR$7,500USD£5,766GBP
- Report
- February 2021
- 50 Pages
Global
From €2292EUR$2,600USD£1,999GBP
€2865EUR$3,250USD£2,499GBP
- Report
- April 2020
- 80 Pages
Global
From €2786EUR$3,160USD£2,430GBP
€3483EUR$3,950USD£3,037GBP
- Report
- July 2024
- 110 Pages
Global
From €4188EUR$4,750USD£3,652GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more